Takeshi Takahashi
Gifu-shi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).
Journal: International journal of hematology
Published: May 24, 2019
Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study.
Journal: International journal of hematology
Published: March 29, 2019
Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).
Journal: International journal of hematology
Published: October 16, 2018
Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study.
Journal: International journal of clinical oncology
Published: March 16, 2018
R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
Journal: Hematological oncology
Published: August 03, 2017
Low dose palliative radiotherapy for refractory aggressive lymphoma.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: June 09, 2016
The Establishment of Indicators of Thrombocytopenia in Patients Receiving Lenalidomide Therapy.
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 27, 2016
A female chronic myeloid leukemia patient who gave birth after stopping imatinib intentionally but who maintained a major molecular response with interferon
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: May 13, 2015
Analysis of factors influencing the occurrence of infusion reaction after initial treatment with rituximab
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 19, 2014
Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone.
Journal: Leukemia & lymphoma
Published: January 28, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026